{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:43:42Z","timestamp":1790624622526,"version":"4.1.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["25345"],"award-info":[{"award-number":["25345"]}],"id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-80119-5","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T16:05:24Z","timestamp":1732550724000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Bilirubin, a hepatoprotective agent that activates SIRT1, PGC-1\u03b1,\u00a0and PPAR-\u03b1, while inhibiting NF-\u03baB in rats with metabolic-associated fatty liver disease"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0256-4910","authenticated-orcid":false,"given":"Motahareh","family":"Taghizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0095-4264","authenticated-orcid":false,"given":"Mohammad Hasan","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9103-872X","authenticated-orcid":false,"given":"Omid","family":"Vakili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvin","family":"Zarei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0360-7468","authenticated-orcid":false,"given":"Amirreza","family":"Dehghanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0363-9523","authenticated-orcid":false,"given":"Hossein","family":"Bordbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9221-2267","authenticated-orcid":false,"given":"Sayed Mohammad","family":"Shafiee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,25]]},"reference":[{"key":"80119_CR1","doi-asserted-by":"publisher","first-page":"100765","DOI":"10.1016\/j.aohep.2022.100765","volume":"27","author":"D Garc\u00eda-Compe\u00e1n","year":"2022","unstructured":"Garc\u00eda-Compe\u00e1n, D. & Jim\u00e9nez-Rodr\u00edguez, A. R. NAFLD vs MAFLD. The evidence-based debate has come. Time to change?. Ann. Hepatol. 27, 100765 (2022).","journal-title":"Ann. Hepatol."},{"key":"80119_CR2","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3390\/antiox10081226","volume":"10","author":"JH Han","year":"2021","unstructured":"Han, J. H., Park, M. H. & Myung, C. S. Garcinia cambogia ameliorates non-alcoholic fatty liver disease by inhibiting oxidative stress-mediated steatosis and apoptosis through NRF2-ARE activation. Antioxidants 10, 1226 (2021).","journal-title":"Antioxidants"},{"key":"80119_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/13813455.2019.1661496","volume":"128","author":"R Ebrahimi","year":"2022","unstructured":"Ebrahimi, R. et al. Low level of adiponectin predicts the development of nonalcoholic fatty liver disease: is it irrespective to visceral adiposity index, visceral adipose tissue thickness and other obesity indices?. Arch. Physiol. Biochem. 128, 24\u201331 (2022).","journal-title":"Arch. Physiol. Biochem."},{"key":"80119_CR4","doi-asserted-by":"publisher","first-page":"106178","DOI":"10.1016\/j.fitote.2024.106178","volume":"178","author":"Q Wang","year":"2024","unstructured":"Wang, Q., Zhang, Y., Lu, R., Zhao, Q. & Gao, Y. The multiple mechanisms and therapeutic significance of rutin in metabolic dysfunction-associated fatty liver disease (MAFLD). Fitoterapia 178, 106178 (2024).","journal-title":"Fitoterapia"},{"key":"80119_CR5","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.3390\/jcm13164857","volume":"13","author":"D Dynka","year":"2024","unstructured":"Dynka, D. et al. Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease (NAFLD\/MAFLD). J. Clin. Med. 13, 4857 (2024).","journal-title":"J. Clin. Med."},{"key":"80119_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13685","author":"M Karin","year":"2024","unstructured":"Karin, M. & Kim, J. Y. MASH as an emerging cause of hepatocellular carcinoma: Current knowledge and future perspectives. Mol. Oncol. https:\/\/doi.org\/10.1002\/1878-0261.13685 (2024).","journal-title":"Mol. Oncol."},{"key":"80119_CR7","doi-asserted-by":"publisher","first-page":"4020249","DOI":"10.1155\/2020\/4020249","volume":"2020","author":"K Pei","year":"2020","unstructured":"Pei, K. et al. An overview of lipid metabolism and nonalcoholic fatty liver disease. Biomed. Res. Int. 2020, 4020249 (2020).","journal-title":"Biomed. Res. Int."},{"key":"80119_CR8","doi-asserted-by":"publisher","first-page":"1060244","DOI":"10.3389\/fmed.2022.1060244","volume":"9","author":"T Yagai","year":"2022","unstructured":"Yagai, T. & Nakamura, T. Mechanistic insights into the peroxisome proliferator-activated receptor alpha as a transcriptional suppressor. Front. Med. 9, 1060244 (2022).","journal-title":"Front. Med."},{"key":"80119_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13098-020-00544-0","volume":"12","author":"R Ebrahimi","year":"2020","unstructured":"Ebrahimi, R. et al. Adipose tissue gene expression of long non-coding RNAs; MALAT1, TUG1 in obesity: Is it associated with metabolic profile and lipid homeostasis-related genes expression?. Diabetol. Metab. Syndr. 12, 36 (2020).","journal-title":"Diabetol. Metab. Syndr."},{"key":"80119_CR10","doi-asserted-by":"publisher","first-page":"10545","DOI":"10.3390\/ijms221910545","volume":"22","author":"M Grabacka","year":"2021","unstructured":"Grabacka, M., Pierzchalska, M., Plonka, P. M. & Pierzchalski, P. The role of PPAR alpha in the modulation of innate immunity. Int. J. Mol. Sci. 22, 10545 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"80119_CR11","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.dld.2020.04.019","volume":"52","author":"M Ortiz","year":"2020","unstructured":"Ortiz, M. et al. Suppression of high-fat diet-induced obesity-associated liver mitochondrial dysfunction by docosahexaenoic acid and hydroxytyrosol co-administration. Dig. Liver Dis. 52, 895\u2013904 (2020).","journal-title":"Dig. Liver Dis."},{"key":"80119_CR12","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/s42255-021-00498-1","volume":"3","author":"DC Levine","year":"2021","unstructured":"Levine, D. C. et al. NADH inhibition of SIRT1 links energy state to transcription during time-restricted feeding. Nat. Metab. 3, 1621\u20131632 (2021).","journal-title":"Nat. Metab."},{"key":"80119_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1186\/s12967-023-04440-9","volume":"21","author":"B Varghese","year":"2023","unstructured":"Varghese, B. et al. SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism. J. Transl. Med. 21, 627 (2023).","journal-title":"J. Transl. Med."},{"key":"80119_CR14","doi-asserted-by":"publisher","first-page":"155285","DOI":"10.1016\/j.phymed.2023.155285","volume":"124","author":"J Liao","year":"2024","unstructured":"Liao, J. et al. Formononetin promotes fatty acid beta-oxidation to treat non-alcoholic steatohepatitis through SIRT1\/PGC-1alpha\/PPARalpha pathway. Phytomedicine 124, 155285 (2024).","journal-title":"Phytomedicine"},{"key":"80119_CR15","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.3390\/ijms21113858","volume":"21","author":"E de Gregorio","year":"2020","unstructured":"de Gregorio, E., Colell, A., Morales, A. & Mar\u00ed, M. Relevance of SIRT1-NF-\u03baB axis as therapeutic target to ameliorate inflammation in liver disease. Int. J. Mol. Sci. 21, 3858 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"80119_CR16","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.2147\/DMSO.S437865","volume":"16","author":"D Meng","year":"2023","unstructured":"Meng, D. et al. Biological role and related natural products of SIRT1 in nonalcoholic fatty liver. Diabetes Metab. Syndr. Obes. 16, 4043\u20134064 (2023).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"80119_CR17","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3390\/biomedicines10030696","volume":"10","author":"A Bianco","year":"2022","unstructured":"Bianco, A., Tiribelli, C. & Bellarosa, C. Translational approach to the protective effect of bilirubin in diabetic kidney disease. Biomedicines 10, 696 (2022).","journal-title":"Biomedicines"},{"key":"80119_CR18","doi-asserted-by":"publisher","first-page":"14276","DOI":"10.3390\/ijms232214276","volume":"23","author":"S Jayanti","year":"2022","unstructured":"Jayanti, S., Moretti, R., Tiribelli, C. & Gazzin, S. Bilirubin prevents the TH(+) dopaminergic neuron loss in a parkinson\u2019s disease model by acting on TNF-alpha. Int. J. Mol. Sci. 23, 14276 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"80119_CR19","doi-asserted-by":"publisher","first-page":"522","DOI":"10.21037\/atm-22-1187","volume":"10","author":"X Shu","year":"2022","unstructured":"Shu, X. et al. Association between bilirubin and nonalcoholic fatty liver disease in the non-obese chinese population: A cross-sectional study. Ann. Transl. Med. 10, 522 (2022).","journal-title":"Ann. Transl. Med."},{"key":"80119_CR20","doi-asserted-by":"publisher","first-page":"110490","DOI":"10.1016\/j.cbi.2023.110490","volume":"378","author":"MH Maleki","year":"2023","unstructured":"Maleki, M. H. et al. Bilirubin improves renal function by reversing the endoplasmic reticulum stress and inflammation in the kidneys of type 2 diabetic rats fed high-fat diet. Chem. Biol. Interact. 378, 110490 (2023).","journal-title":"Chem. Biol. Interact."},{"key":"80119_CR21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bbrc.2023.06.050","volume":"672","author":"M Niknam","year":"2023","unstructured":"Niknam, M. et al. Bilirubin, an endogenous antioxidant that affects p53 protein and its downstream apoptosis\/autophagy-related genes in LS180 and SW480 cell culture models of colorectal cancer. Biochem. Biophys. Res. Commun. 672, 161\u2013167 (2023).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"80119_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12950-024-00397-8","volume":"21","author":"MH Maleki","year":"2024","unstructured":"Maleki, M. H. et al. Protective and curative effects of unconjugated bilirubin on gene expression of LOX-1 and iNOS in the heart of rats receiving high-fat diet and low dose streptozotocin: A histomorphometric approach. J. Inflamm. 21, 26 (2024).","journal-title":"J. Inflamm."},{"key":"80119_CR23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.4103\/RPS.RPS_53_24","volume":"19","author":"R Tavakoli","year":"2024","unstructured":"Tavakoli, R. et al. Bilirubin, once a toxin but now an antioxidant alleviating non-alcoholic fatty liver disease in an autophagy-dependent manner in high-fat diet-induced rats: A molecular and histopathological analysis. Res. Pharm. Sci. 19, 475\u2013488 (2024).","journal-title":"Res. Pharm. Sci."},{"key":"80119_CR24","doi-asserted-by":"publisher","first-page":"869579","DOI":"10.3389\/fendo.2022.869579","volume":"13","author":"C Liang","year":"2022","unstructured":"Liang, C. et al. Association of serum bilirubin with metabolic syndrome and non-alcoholic fatty liver disease: A systematic review and meta-analysis. Front. Endocrinol. 13, 869579 (2022).","journal-title":"Front. Endocrinol."},{"key":"80119_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/biom13020252","volume":"13","author":"EA Bates","year":"2023","unstructured":"Bates, E. A. et al. Suppressing hepatic UGT1A1 increases plasma bilirubin, lowers plasma urobilin, reorganizes kinase signaling pathways and lipid species and improves fatty liver disease. Biomolecules 13, 252 (2023).","journal-title":"Biomolecules"},{"key":"80119_CR26","doi-asserted-by":"publisher","first-page":"G668","DOI":"10.1152\/ajpgi.00026.2018","volume":"314","author":"L Weaver","year":"2018","unstructured":"Weaver, L., Hamoud, A. R., Stec, D. E. & Hinds, T. D. Biliverdin reductase and bilirubin in hepatic disease. Am. J. Physiol. Gastrointest. Liver Physiol. 314, G668\u2013G676 (2018).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"80119_CR27","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.jhep.2021.06.010","volume":"75","author":"L Vitek","year":"2021","unstructured":"Vitek, L. & Tiribelli, C. Bilirubin: The yellow hormone?. J. Hepatol. 75, 1485\u20131490 (2021).","journal-title":"J. Hepatol."},{"key":"80119_CR28","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1007\/s11033-023-08339-y","volume":"50","author":"O Vakili","year":"2023","unstructured":"Vakili, O., Borji, M., Saffari-Chaleshtori, J. & Shafiee, S. M. Ameliorative effects of bilirubin on cell culture model of non-alcoholic fatty liver disease. Mol. Biol. Rep. 50, 4411\u20134422 (2023).","journal-title":"Mol. Biol. Rep."},{"key":"80119_CR29","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1126\/science.3029864","volume":"235","author":"R Stocker","year":"1987","unstructured":"Stocker, R., Yamamoto, Y., McDonagh, A. F., Glazer, A. N. & Ames, B. N. Bilirubin is an antioxidant of possible physiological importance. Science 235, 1043\u20131046 (1987).","journal-title":"Science"},{"key":"80119_CR30","doi-asserted-by":"publisher","first-page":"9804","DOI":"10.1074\/jbc.RA120.013700","volume":"295","author":"DM Gordon","year":"2020","unstructured":"Gordon, D. M. et al. Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator-activated receptor alpha. J. Biol. Chem. 295, 9804\u20139822 (2020).","journal-title":"J. Biol. Chem."},{"key":"80119_CR31","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.3390\/molecules26102975","volume":"26","author":"DM Gordon","year":"2021","unstructured":"Gordon, D. M., Hong, S. H., Kipp, Z. A. & Hinds, T. D. Jr. Identification of binding regions of bilirubin in the ligand-binding pocket of the peroxisome proliferator-activated receptor-a (PPARalpha). Molecules 26, 2975 (2021).","journal-title":"Molecules"},{"key":"80119_CR32","doi-asserted-by":"publisher","first-page":"E191","DOI":"10.1152\/ajpendo.00405.2020","volume":"320","author":"JF Creeden","year":"2021","unstructured":"Creeden, J. F., Gordon, D. M., Stec, D. E. & Hinds, T. D. Jr. Bilirubin as a metabolic hormone: The physiological relevance of low levels. Am. J. Physiol. Endocrinol. Metab. 320, E191\u2013E207 (2021).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"80119_CR33","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/cpt.2441","volume":"111","author":"JT Zanussi","year":"2022","unstructured":"Zanussi, J. T. et al. Identifying potential therapeutic applications and diagnostic harms of increased bilirubin concentrations: A clinical and genetic approach. Clin. Pharmacol. Ther. 111, 435\u2013443 (2022).","journal-title":"Clin. Pharmacol. Ther."},{"key":"80119_CR34","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.lfs.2006.03.021","volume":"79","author":"Y Zou","year":"2006","unstructured":"Zou, Y. et al. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life Sci. 79, 1100\u20131107 (2006).","journal-title":"Life Sci."},{"key":"80119_CR35","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.biopha.2017.08.098","volume":"95","author":"S Gheibi","year":"2017","unstructured":"Gheibi, S., Kashfi, K. & Ghasemi, A. A practical guide for induction of type-2 diabetes in rat: Incorporating a high-fat diet and streptozotocin. Biomed. Pharmacother. 95, 605\u2013613 (2017).","journal-title":"Biomed. Pharmacother."},{"key":"80119_CR36","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1161\/CIRCULATIONAHA.106.633206","volume":"114","author":"JP Lin","year":"2006","unstructured":"Lin, J. P. et al. Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the framingham heart study. Circulation 114, 1476\u20131481 (2006).","journal-title":"Circulation"},{"key":"80119_CR37","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1210\/en.2013-1667","volume":"155","author":"H Dong","year":"2014","unstructured":"Dong, H. et al. Bilirubin increases insulin sensitivity in leptin-receptor deficient and diet-induced obese mice through suppression of ER stress and chronic inflammation. Endocrinology 155, 818\u2013828 (2014).","journal-title":"Endocrinology"},{"key":"80119_CR38","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.3390\/pharmaceutics15061582","volume":"15","author":"MD Joshi","year":"2023","unstructured":"Joshi, M. D., Iacoban, P. & Scheetz, M. H. Pharmacokinetic and biomarker quantification studies on vancomycin-loaded PEGylated liposomes and its potential to reduce vancomycin-induced kidney injury: A rat study. Pharmaceutics 15, 1582 (2023).","journal-title":"Pharmaceutics"},{"key":"80119_CR39","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1093\/cid\/ciz146","volume":"69","author":"KJ Graves","year":"2019","unstructured":"Graves, K. J. et al. Trichomonas vaginalis virus among women with trichomoniasis and associations with demographics, clinical outcomes, and metronidazole resistance. Clin. Infect. Dis. 69, 2170\u20132176 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"80119_CR40","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1111\/dom.15810","volume":"26","author":"MH Maleki","year":"2024","unstructured":"Maleki, M. H. et al. Attenuation of brown adipocyte whitening in high-fat diet-induced obese rats: Effects of melatonin and beta-hydroxybutyrate on Cidea, Fsp27 and MT1 expression. Diabetes Obes. Metab. 26, 4551\u20134561 (2024).","journal-title":"Diabetes Obes. Metab."},{"key":"80119_CR41","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3390\/diagnostics13050984","volume":"13","author":"MA Amin","year":"2023","unstructured":"Amin, M. A., Ragab, H. M., Abd El Maksoud, N. & Elaziz, W. A. CD24 gene expression as a risk factor for non-alcoholic fatty liver disease. Diagnostics 13, 984 (2023).","journal-title":"Diagnostics"},{"key":"80119_CR42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1083\/jcb.30.1.23","volume":"30","author":"ER Weibel","year":"1966","unstructured":"Weibel, E. R., Kistler, G. S. & Scherle, W. F. Practical stereological methods for morphometric cytology. J. Cell Biol. 30, 23\u201338 (1966).","journal-title":"J. Cell Biol."},{"key":"80119_CR43","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3746\/pnf.2015.20.4.266","volume":"20","author":"A Rafati","year":"2015","unstructured":"Rafati, A. et al. Mitigating effect of resveratrol on the structural changes of mice liver and kidney induced by cadmium; a stereological study. Prev. Nutr. Food Sci. 20, 266\u2013275 (2015).","journal-title":"Prev. Nutr. Food Sci."},{"key":"80119_CR44","first-page":"218","volume":"46","author":"H Bordbar","year":"2021","unstructured":"Bordbar, H., Soleymani, F., Nadimi, E., Yahyavi, S. S. & Fazelian-Dehkordi, K. A quantitative study on the protective effects of resveratrol against bisphenol a-induced hepatotoxicity in rats: A stereological study. Iran. J. Med. Sci. 46, 218\u2013227 (2021).","journal-title":"Iran. J. Med. Sci."},{"key":"80119_CR45","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.micron.2008.12.006","volume":"40","author":"S Karbalay-Doust","year":"2009","unstructured":"Karbalay-Doust, S. & Noorafshan, A. Stereological study of the effects of nandrolone decanoate on the mouse liver. Micron 40, 471\u2013475 (2009).","journal-title":"Micron"},{"key":"80119_CR46","first-page":"66","volume":"10","author":"CS von Bartheld","year":"2012","unstructured":"von Bartheld, C. S. Distribution of particles in the z-axis of tissue sections: Relevance for counting methods. Neuroquantology 10, 66\u201375 (2012).","journal-title":"Neuroquantology"},{"key":"80119_CR47","doi-asserted-by":"publisher","first-page":"101871","DOI":"10.1016\/j.jchemneu.2020.101871","volume":"110","author":"MR Namavar","year":"2020","unstructured":"Namavar, M. R., Ghalavandi, M. & Bahmanpour, S. The effect of glutathione and buserelin on the stereological parameters of the hypothalamus in the cyclophosphamide-treated mice. J. Chem. Neuroanat. 110, 101871 (2020).","journal-title":"J. Chem. Neuroanat."},{"key":"80119_CR48","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4132\/jptm.2020.03.07","volume":"54","author":"K Lee","year":"2020","unstructured":"Lee, K. et al. A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy. J. Pathol. Transl. Med. 54, 228\u2013236 (2020).","journal-title":"J. Pathol. Transl. Med."},{"key":"80119_CR49","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/genes13020315","volume":"13","author":"F Cioffi","year":"2022","unstructured":"Cioffi, F. et al. Altered mitochondrial quality control in rats with metabolic dysfunction-associated fatty liver disease (MAFLD) induced by high-fat feeding. Genes 13, 315 (2022).","journal-title":"Genes"},{"key":"80119_CR50","first-page":"333","volume":"19","author":"M Koushki","year":"2020","unstructured":"Koushki, M. et al. Resveratrol reduces lipid accumulation through upregulating the expression of microRNAs regulating fatty acid bet oxidation in liver cells: Evidence from in-vivo and in-vitro studies. Iran. J. Pharm. Res. 19, 333\u2013340 (2020).","journal-title":"Iran. J. Pharm. Res."},{"key":"80119_CR51","doi-asserted-by":"publisher","first-page":"1074911","DOI":"10.3389\/fendo.2022.1074911","volume":"13","author":"Y Lin","year":"2022","unstructured":"Lin, Y., Wang, Y. & Li, P. F. PPARalpha: An emerging target of metabolic syndrome, neurodegenerative and cardiovascular diseases. Front. Endocrinol. 13, 1074911 (2022).","journal-title":"Front. Endocrinol."},{"key":"80119_CR52","doi-asserted-by":"publisher","first-page":"4136","DOI":"10.3748\/wjg.v29.i26.4136","volume":"29","author":"H Souza-Tavares","year":"2023","unstructured":"Souza-Tavares, H. et al. Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas. World J. Gastroenterol. 29, 4136\u20134155 (2023).","journal-title":"World J. Gastroenterol."},{"key":"80119_CR53","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/gutjnl-2015-310798","volume":"65","author":"A Montagner","year":"2016","unstructured":"Montagner, A. et al. Liver PPARalpha is crucial for whole-body fatty acid homeostasis and is protective against NAFLD. Gut 65, 1202\u20131214 (2016).","journal-title":"Gut"},{"key":"80119_CR54","doi-asserted-by":"publisher","first-page":"6489","DOI":"10.1038\/s41598-020-63579-3","volume":"10","author":"M Regnier","year":"2020","unstructured":"Regnier, M. et al. Hepatocyte-specific deletion of Pparalpha promotes NAFLD in the context of obesity. Sci. Rep. 10, 6489 (2020).","journal-title":"Sci. Rep."},{"key":"80119_CR55","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.cmet.2009.02.006","volume":"9","author":"A Purushotham","year":"2009","unstructured":"Purushotham, A. et al. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab. 9, 327\u2013338 (2009).","journal-title":"Cell Metab."},{"key":"80119_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-018-3368-y","volume":"450","author":"X Liu","year":"2019","unstructured":"Liu, X. et al. Silibinin-induced autophagy mediated by PPARalpha-sirt1-AMPK pathway participated in the regulation of type I collagen-enhanced migration in murine 3T3-L1 preadipocytes. Mol. Cell. Biochem. 450, 1\u201323 (2019).","journal-title":"Mol. Cell. Biochem."},{"key":"80119_CR57","doi-asserted-by":"publisher","first-page":"831879","DOI":"10.3389\/fnut.2022.831879","volume":"9","author":"JH Suh","year":"2022","unstructured":"Suh, J. H., Kim, K. H., Conner, M. E., Moore, D. D. & Preidis, G. A. Hepatic PPARalpha is destabilized by SIRT1 deacetylase in undernourished male mice. Front. Nutr. 9, 831879 (2022).","journal-title":"Front. Nutr."},{"key":"80119_CR58","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11010-010-0391-z","volume":"339","author":"S Hayashida","year":"2010","unstructured":"Hayashida, S. et al. Fasting promotes the expression of SIRT1, an NAD+ -dependent protein deacetylase, via activation of PPARalpha in mice. Mol. Cell. Biochem. 339, 285\u2013292 (2010).","journal-title":"Mol. Cell. Biochem."},{"key":"80119_CR59","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.clnesp.2023.10.013","volume":"58","author":"H Tutunchi","year":"2023","unstructured":"Tutunchi, H. et al. Effects of oleoylethanolamide supplementation on the expression of lipid metabolism-related genes and serum NRG4 levels in patients with non-alcoholic fatty liver disease: A randomized controlled trial. Clin. Nutr. ESPEN 58, 311\u2013319 (2023).","journal-title":"Clin. Nutr. ESPEN"},{"key":"80119_CR60","doi-asserted-by":"publisher","first-page":"e0153427","DOI":"10.1371\/journal.pone.0153427","volume":"11","author":"DE Stec","year":"2016","unstructured":"Stec, D. E. et al. Bilirubin binding to PPARalpha inhibits lipid accumulation. PLoS One 11, e0153427 (2016).","journal-title":"PLoS One"},{"key":"80119_CR61","doi-asserted-by":"publisher","first-page":"101177","DOI":"10.1016\/j.aohep.2023.101177","volume":"29","author":"H Han","year":"2024","unstructured":"Han, H. et al. Non-linear associations of circulating total bilirubin concentration with the risk of nonalcoholic fatty liver disease and all-cause mortality. Ann. Hepatol. 29, 101177 (2024).","journal-title":"Ann. Hepatol."},{"key":"80119_CR62","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3390\/biology11050792","volume":"11","author":"S Todisco","year":"2022","unstructured":"Todisco, S. et al. PPAR alpha as a metabolic modulator of the liver: Role in the pathogenesis of nonalcoholic steatohepatitis (NASH). Biology 11, 792 (2022).","journal-title":"Biology"},{"key":"80119_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.831168","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Regulation of SIRT1 and its roles in inflammation. Front. Immunol. 13, 831168 (2022).","journal-title":"Front. Immunol."},{"key":"80119_CR64","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.cellsig.2013.06.007","volume":"25","author":"A Kauppinen","year":"2013","unstructured":"Kauppinen, A., Suuronen, T., Ojala, J., Kaarniranta, K. & Salminen, A. Antagonistic crosstalk between NF-kappaB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell. Signal. 25, 1939\u20131948 (2013).","journal-title":"Cell. Signal."},{"key":"80119_CR65","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.bbrc.2010.05.160","volume":"397","author":"HN Zhang","year":"2010","unstructured":"Zhang, H. N. et al. Involvement of the p65\/RelA subunit of NF-kappaB in TNF-alpha-induced SIRT1 expression in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 397, 569\u2013575 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"80119_CR66","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1868-7083-5-11","volume":"5","author":"J Katto","year":"2013","unstructured":"Katto, J., Engel, N., Abbas, W., Herbein, G. & Mahlknecht, U. Transcription factor NFkappaB regulates the expression of the histone deacetylase SIRT1. Clin. Epigenet. 5, 11 (2013).","journal-title":"Clin. Epigenet."},{"key":"80119_CR67","doi-asserted-by":"publisher","first-page":"881462","DOI":"10.3389\/fcimb.2022.881462","volume":"12","author":"R Lucarelli","year":"2022","unstructured":"Lucarelli, R. et al. Eicosanoid-activated PPARalpha inhibits NFkappaB-dependent bacterial clearance during post-influenza superinfection. Front. Cell. Infect. Microbiol. 12, 881462 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"80119_CR68","first-page":"4279","volume":"14","author":"Y Guo","year":"2017","unstructured":"Guo, Y. et al. Targeting Sirt1 in a rat model of high-fat diet-induced non-alcoholic fatty liver disease: Comparison of Gegen Qinlian decoction and resveratrol. Exp. Ther. Med. 14, 4279\u20134287 (2017).","journal-title":"Exp. Ther. Med."},{"key":"80119_CR69","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1055\/s-0038-1660523","volume":"38","author":"F Schepis","year":"2018","unstructured":"Schepis, F., Turco, L., Bianchini, M. & Villa, E. Prevention and management of bleeding risk related to invasive procedures in cirrhosis. Semin. Liver Dis. 38, 215\u2013229 (2018).","journal-title":"Semin. Liver Dis."},{"key":"80119_CR70","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/HEP.0000000000000207","volume":"78","author":"MJ McConnell","year":"2023","unstructured":"McConnell, M. J., Kostallari, E., Ibrahim, S. H. & Iwakiri, Y. The evolving role of liver sinusoidal endothelial cells in liver health and disease. Hepatology 78, 649\u2013669 (2023).","journal-title":"Hepatology"},{"key":"80119_CR71","first-page":"93","volume":"20","author":"BZ Altunkaynak","year":"2009","unstructured":"Altunkaynak, B. Z. & Ozbek, E. Overweight and structural alterations of the liver in female rats fed a high-fat diet: A stereological and histological study. Turk. J. Gastroenterol. 20, 93\u2013103 (2009).","journal-title":"Turk. J. Gastroenterol."},{"key":"80119_CR72","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s10620-009-0815-3","volume":"55","author":"ZJ Xu","year":"2010","unstructured":"Xu, Z. J., Fan, J. G., Ding, X. D., Qiao, L. & Wang, G. L. Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats. Dig. Dis. Sci. 55, 931\u2013940 (2010).","journal-title":"Dig. Dis. Sci."},{"key":"80119_CR73","doi-asserted-by":"publisher","first-page":"e13081","DOI":"10.1111\/obr.13081","volume":"21","author":"I Preguica","year":"2020","unstructured":"Preguica, I. et al. Diet-induced rodent models of obesity-related metabolic disorders-A guide to a translational perspective. Obes. Rev. 21, e13081 (2020).","journal-title":"Obes. Rev."},{"key":"80119_CR74","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.21037\/atm-21-2264","volume":"9","author":"SM Schroeder","year":"2021","unstructured":"Schroeder, S. M., Matsukuma, K. E. & Medici, V. Wilson disease and the differential diagnosis of its hepatic manifestations: A narrative review of clinical, laboratory, and liver histological features. Ann. Transl. Med. 9, 1394 (2021).","journal-title":"Ann. Transl. Med."},{"key":"80119_CR75","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40360-021-00524-8","volume":"22","author":"R Akbari","year":"2021","unstructured":"Akbari, R. et al. Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis. BMC Pharmacol. Toxicol. 22, 53 (2021).","journal-title":"BMC Pharmacol. Toxicol."},{"key":"80119_CR76","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/metabo13010014","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. HIIT ameliorates inflammation and lipid metabolism by regulating macrophage polarization and mitochondrial dynamics in the liver of type 2 diabetes mellitus mice. Metabolites 13, 14 (2022).","journal-title":"Metabolites"},{"key":"80119_CR77","doi-asserted-by":"publisher","first-page":"E244","DOI":"10.1152\/ajpendo.00396.2016","volume":"312","author":"TD Hinds Jr","year":"2017","unstructured":"Hinds, T. D. Jr. et al. Mice with hyperbilirubinemia due to Gilbert\u2019s syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPARalpha. Am. J. Physiol. Endocrinol. Metab. 312, E244\u2013E252 (2017).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"80119_CR78","doi-asserted-by":"publisher","first-page":"594574","DOI":"10.3389\/fphar.2020.594574","volume":"11","author":"TD Hinds Jr","year":"2020","unstructured":"Hinds, T. D. Jr. et al. Bilirubin nanoparticles reduce diet-induced hepatic steatosis, improve fat utilization, and increase plasma beta-hydroxybutyrate. Front. Pharmacol. 11, 594574 (2020).","journal-title":"Front. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80119-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80119-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80119-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T17:06:55Z","timestamp":1732554415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80119-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,25]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["80119"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-80119-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,25]]},"assertion":[{"value":"5 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Institutional Animal Ethics Committee of Shiraz University of Medical Sciences, Shiraz, Iran (IR.SUMS.AEC.1401.066). Furthermore, the whole study has been reported in accordance with the ARRIVE guidelines 2.0 (ARRIVE Essential 10) .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"29244"}}